Patent Assignment
Reel/Frame 025445/0807
Change of Name
Recorded: 2010-12-07
Pages: 6
Assignor
FACET BIOTECH CORPORATION
Executed: 2010-09-08
Assignee
ABBOTT BIOTHERAPEUTICS CORP.
1500 SEAPORT BLVD., REDWOOD CITY, CALIFORNIA, 94063
Covered Properties
(64)
Bispecific Antibody Heterodimers
Patent:
5,932,448 →
Application:
07/801,798 →
Cross-Reacting Monoclonal Antibodies Specific for E- and P-Selectin
Patent:
5,622,701 →
Application:
08/259,963 →
Bispecific Antibody Effective to Treat B-Cell Lymphoma and Cell Line
Patent:
6,129,914 →
Application:
08/397,411 →
Humanized Antibodies Reactive with L-Selectin
Patent:
6,210,671 →
Application:
08/579,378 →
Cross-Reacting Monoclonal Antibodies Specific for E-Selectin and P-Selectin
Patent:
6,210,670 →
Application:
08/619,491 →
Monoclonal Antibodies Specific for the Platelet Derived Growth Factor Beta Receptor and Methods of Use Thereof
Patent:
5,882,644 →
Application:
08/621,751 →
Fas Ligand Fusion Proteins and Their Uses
Patent:
6,046,310 →
Application:
08/815,190 →
Method of Preventing Acute Rejection Following Solid Organ Transplantation
Patent:
6,013,256 →
Application:
08/934,841 →
Humanized Antibodies to Gamma-Interferon
Patent:
6,329,511 →
Application:
09/450,520 →
Animal Model for Psoriasis for the Prevention and Treatment of Psoriasis in Humans
Patent:
6,410,824 →
Application:
09/457,912 →
Novel Methods of Diagnosing Cancer, Compositions, and Methods of Screening for Cancer Modulators
Patent:
6,566,502 →
Application:
09/608,821 →
Humanized Antibodies Against CD3
Patent:
7,381,803 →
Application:
09/618,380 →
Novel Methods for Detection and Diagnosing of Breast Cancer
Humanized Antibodies to Gamma-Interferon
Method of treating psoriasis using anti-interleukin 12 antibody
Application:
10/108,191 →
Publication:
US 2002/0194631
Methods of Diagnosis of Ovarian Cancer, Compositions and Methods of Screening for Modulators of Ovarian Cancer
Anti-Hla-Dr Antibodies and the Methods of Using Thereof
Stable liquid pharmaceutical formulation of IgG antibodies
Application:
10/291,528 →
Publication:
US 2003/0138417
Anti-CCR5 Antibody
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Treatment of Inflammatory Bowel Diseases with Anti-Ip-10 Antibodies
Alteration of Fcrn Binding Affinities or Serum Half-Lives of Antibodies by Mutagenesis
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Antibodies Against GPR64 and Uses Thereof
Amphiregulin Antibodies and Their Use to Treat Cancer and Psoriasis
Alteration of Fcrn Binding Affinities or Serum Half-Lives of Antibodies by Mutagenesis
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Alteration of Fc-Fusion Protein Serum Half-Lives by Mutagenesis
Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer
Use of Anti-ALPHA5BETA1 Antibodies to Inhibit Cancer Cell Proliferation
Alteration of Fcrn Binding Affinities or Serum Half-Lives of Antibodies by Mutagenesis
Stable Lyophilized Pharmaceutical Formulation of Igg Antibodies
Anti-CCR5 Antibody
Anti-CCR5 Antibody
Methods of Diagnosis of Ovarian Cancer, Compositions and Methods of Screening for Modulators of Ovarian Cancer
Alteration of Fc-Fusion Protein Serum Half-Lives by Mutagenesis
Compositions and Methods Using Anti-CS1 Antibodies to Treat Multiple Myeloma
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Chimeric and Humanized Antibodies to ALPHA5BETA1 Integrin That Modulate Angiogenesis
Antibodies Against GPR64 and Uses Thereof
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Tethered Vectors for Cell Surface Immunoglobulin Display
Therapeutic Use of Anti-Tweak Receptor Antibodies
Antibodies Against GPR64 and Uses Thereof
Immunoglobulin Display Vectors
Methods of Screening Complex Protein Libraries to Identify Altered Properties
Stable Lyophilized Pharmaceutical Formulation of Igg Antibodies
Method for Treating Multiple Sclerosis Patients with Anti-IL2R Antibodies
Application:
12/549,501 →
Publication:
US 2010/0055098
Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation
Application:
12/642,687 →
Publication:
US 2010/0291111
Mammalian Cell-Based Immunoglobulin Display Libraries
Alteration of Fc-Fusion Protein Serum Half-Lives by Mutagenesis
Anti-Tnf-Alpha Antibodies and Their Uses
Methods for Monitoring the Efficacy of Anti-Il-2R Antibodies in Multiple Sclerosis Patients
Application:
12/768,131 →
Publication:
US 2010/0273204
Anti-Vegf Antibodies and Their Uses
Use of an Immunoregulatory Nk Cell Population for Monitoring the Efficacy of Anti-Il-2R Antibodies in Multiple Sclerosis Patients
Application:
12/872,886 →
Publication:
US 2011/0053209
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Compositions and Methods Using Anti-CS1 Antibodies to Treat Multiple Myeloma
Application:
12/903,051 →
Publication:
US 2011/0165154
Anti-Egfr Antibodies and Their Uses
Use of Immunoregulatory Nk Cell Populations for Predicting the Efficacy of Anti-Il-2R Antibodies in Multiple Sclerosis Patients
Application:
12/915,659 →
Publication:
US 2011/0104153
CTLA4 Proteins and Their Uses
Application:
61/313,516 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 28, 1996
From: CHANG, CHUNG NAN; LANDOLFI, NICHOLAS; MARTIN, ULRICH
To: PROTEIN DESIGN LABS, INC.; BOEHRINGER MANNHEIM GMBH
Reel/Frame 008148/0308 →
Assignment of Assignor's Interest
Aug 13, 2003
From: BHASKAR, VINAY; CALLE, AGUSTIN DE LA; LAW, DEBBIE; CARAS, INGRID
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014391/0598 →
Assignment of Assignor's Interest
Aug 18, 2003
From: OLSON, WILLIAM C.; MADDON, PAUL J.
To: PROGENICS PHARMACEUTICALS, INC.
Reel/Frame 014393/0471 →
Assignment of Assignor's Interest
Aug 18, 2003
From: TSURUSHITA, NAOYA; HINTON, PAUL R.; VASQUEZ, MAXIMILLANO
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014392/0780 →
Assignment of Assignor's Interest
Sep 25, 2003
From: VASQUEZ, MAXIMILIANO; LANDOLFI, NICHOLAS F.; TSURUSHITA, NAOYA; QUEEN, CARY L.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014562/0232 →
Assignment of Assignor's Interest
Feb 6, 2004
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014967/0744 →
Assignment of Assignor's Interest
Oct 14, 2004
From: HINTON, PAUL R; TSURUSHITA, NAOYA; TSO, J. YUN; VASQUEZ, MAXIMILIANO
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 015250/0453 →
Assignment of Assignor's Interest
Jan 17, 2006
From: ROCHE DIAGNOSTICS GMBH
To: PDL BIOPHARMA, INC.
Reel/Frame 017015/0693 →
Change of Name
Feb 17, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017186/0110 →
Assignment of Assignor's Interest
Apr 5, 2006
From: KAISHEVA, ELIZABET A.; GUPTA, SUPRIYA; DUVUR, SHANTI G.; SUBRAMANIAN, MALATHY
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 017427/0209 →
Change of Name
Apr 7, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017439/0502 →
Merger
Apr 11, 2006
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 017455/0630 →
Change of Name
Apr 13, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017465/0495 →
Change of Name
May 1, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017555/0284 →
Merger
May 1, 2006
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 017555/0288 →
Change of Name
May 19, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017636/0787 →
Change of Name
May 22, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017655/0436 →
Assignment of Assignor's Interest
May 22, 2006
From: MCPHATE GREEN, JENNIFER; TSO, J. YUN
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 017649/0446 →
Assignment of Assignor's Interest
Jul 21, 2006
From: BALASA, BALAJI; TSURUSHITA, NAOYA; LANDOLFI, NICHOLAS F.
To: PDL BIOPHARMA, INC.
Reel/Frame 017974/0498 →
Assignment of Assignor's Interest
Mar 4, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022343/0275 →
Assignment of Assignor's Interest
Mar 4, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022343/0269 →
Assignment of Assignor's Interest
Apr 13, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022537/0440 →
Assignment of Assignor's Interest
Apr 13, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022537/0360 →
Assignment of Assignor's Interest
Aug 5, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 023056/0251 →
Assignment of Assignor's Interest
Sep 18, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 023245/0973 →